Cyron Therapeutics CEO has been invited as a keynote speaker at Asia's largest bio conference 'BIO Asia 2025' to be held in Tokyo this March.
The CEO will share Cyron's AI-based drug development experience and personalized treatment development strategies under the theme 'The Future of AI and Precision Medicine'. The presentation will include precision medicine approaches considering Asian patients' genetic characteristics and methods to accelerate drug development using AI.
BIO Asia is Asia's largest bio event with over 5,000 bio industry leaders participating worldwide. Being invited as a keynote speaker is considered an indicator of a company's global standing.
At the conference, Cyron Therapeutics will operate a separate booth and conduct partnership meetings with global pharmaceutical companies. The industry expects announcements of additional technology transfers or investment deals through this event.